凯杰生物

最新新闻

• 评级变动
  Berenberg Bank Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $45.74
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• 评级变动
  Barclays Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $38
  \u5e02\u573a\u8d44\u8baf · 2026/6/24
• 公司公告
  Qiagen NV: QIAGEN N.V. - Share Consolidation/Cash Distribution Option Symbol: QGEN New Symbol: QGEN1
  OCC · 2026/1/8
• 公司公告
  Qiagen NV: QIAGEN N.V. - Anticipated Share Consolidation/Cash Distribution Option Symbol: QGEN New Symbol: QGEN1
  OCC · 2024/1/27
• Deutsche Bank Maintains Qiagen NV(QGEN.US) With Buy Rating, Announces Target Price $53.46
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• 评级变动
  J.P. Morgan Maintains Qiagen NV(QGEN.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/10
• 评级变动
  William Blair Initiates Qiagen NV(QGEN.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/10
• QIAGEN Appoints Jonathan M. Pratt As Chief Executive Officer QGEN
  Dow Jones · 2026/8/24
• 评级变动
  TD Cowen Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $44
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• 评级变动
  A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $45.5 to $46.09
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• Berenberg Bank Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $45.5
  \u5e02\u573a\u8d44\u8baf · 2026/9/11
• 评级变动
  Jefferies Maintains Qiagen NV(QGEN.US) With Buy Rating, Announces Target Price $46
  \u5e02\u573a\u8d44\u8baf · 2026/7/10
• 公司公告
  Qiagen NV: QIAGEN N.V. - Share Consolidation/Cash Distribution Option Symbol: QGEN New Symbol: QGEN1
  OCC · 2024/1/30
• 评级变动
  Berenberg Bank Downgrades Qiagen NV(QGEN.US) to Hold Rating, Cuts Target Price to $45.56
  \u5e02\u573a\u8d44\u8baf · 2026/7/14
• J.P. Morgan Maintains Qiagen NV(QGEN.US) With Buy Rating, Announces Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  Morgan Stanley Upgrades Qiagen NV(QGEN.US) to Buy Rating, Raises Target Price to $42
  \u5e02\u573a\u8d44\u8baf · 2026/6/23
• William Blair Maintains Qiagen NV(QGEN.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 评级变动
  Morgan Stanley Maintains Qiagen NV(QGEN.US) With Buy Rating, Raises Target Price to $46.25
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• 评级变动
  Citi Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $45
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  Deutsche Bank Maintains Qiagen NV(QGEN.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/10

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。